In conclusion, the expression of SETMAR in thyroid cancer is stabilized by METTL3‐mediated m6A modification in an IGF2BP3‐dependent manner, which could explain its dysregulation during dedifferentiation of thyroid cancer. The gene discussed is IGF2BP3; the disease is thyroid gland carcinoma.